In fact, inflammatory markers like high-sensitive CRP (hsCRP) and IL-6 are elevated in patients with recurrent AF in an early non-permanent stage of AF [46], but these particular patients did not benefit from Ang II receptor inhibition [47]. This evidence concerns the gene IL6 and atrial fibrillation.